The Child with Rare Disease

according the United Nations Convention on the Rights of the Child

The Importance of Pediatrics in Diagnosing Rare Diseases

By Redação

Source: PENIDO, Maria Goretti Moreira Guimarães; VAISBICH, Maria Helena; PALMA, Lilian Monteiro Pereira; BRESOLIN, Nilzete Liberato. Rare Diseases: What Pediatricians Need to Know. Resid Pediatr., v. 14, n. 1, 2024. DOI: 10.25060/residpediatr-2024.v14n1-1062.

👶🏽 Early diagnosis of rare diseases in pediatrics can significantly change patients’ lives.

  • Why it matters: Pediatricians are often the first to identify signs of rare diseases in children, and are key to early diagnosis and treatment.

🧠 What’s happening: Approximately 70% of rare diseases manifest in childhood, making pediatric surveillance essential.

  • Pediatricians should be on the lookout for unusual signs and symptoms in order to recognize them and refer them promptly.

🔍 Between the lines: The diagnosis of rare diseases is challenging due to the variety of manifestations and the lack of widespread medical knowledge.

  • Continuous medical education and awareness of rare diseases among pediatricians are vital to improving early diagnosis.

🏃 In short: Pediatricians play a vital role in the early diagnosis of rare diseases.

  • Early detection and referral can make a big difference to the child’s outcome.

🖼️ The big picture: Pediatrics is key in the fight against rare diseases, with the potential to identify them early and significantly improve the quality of life of young patients.

💭 O ur opinion Pediatricians are essential in the early detection of rare diseases. Increased education and resources for these professionals can speed up diagnosis and treatment, saving and improving lives.

The article in questions and answers

What are the common challenges faced by rare disease patients and their families?

Rare disease patients and their families face many challenges, such as:

  1. Time-consuming diagnosis: The process of diagnosing rare diseases can be long and complicated, leading to delays in starting appropriate treatment.
  2. Limited Medical Experience: Many doctors have limited knowledge of rare diseases, which can make accurate diagnosis and timely treatment difficult.
  3. Impact on Quality of Life: Rare diseases are often severe, chronic and debilitating, significantly impacting the quality of life of patients and their families.
  4. Difficulties in Accessing Specialized Services: Limited access to specialized services and referral centers can hinder adequate care for rare disease patients.
  5. Lack of Knowledge and Awareness: Low level of knowledge and awareness of rare diseases among health professionals, medical students and the general population.

These challenges highlight the importance of raising awareness, improving access to specialized services and promoting education about rare diseases to ensure better care and support for patients and their families.

What are some key strategies to improve awareness and treatment adherence for individuals with rare diseases?

Some key strategies to improve awareness and adherence to treatment for rare disease patients include:

  1. Education and Awareness: Promote educational programs for health professionals, medical students and the community in general about rare diseases, symptoms, diagnosis and treatment.
  2. Multidisciplinary Support: Implement multidisciplinary teams that include doctors, nurses, psychologists, nutritionists and social workers to provide comprehensive and personalized care to patients and their families.
  3. Access to Genetic Testing: Ensure access to accurate genetic testing to facilitate early diagnosis and genetic counseling, allowing for a better understanding of the disease and its implications.
  4. Psychosocial Support: Offering psychological and social support to patients and their families, helping them to cope with the emotional and practical impact of the rare disease on their daily lives.
  5. Improving Access to Specialized Services: Investing in referral centers and specialized services to ensure that rare disease patients receive high-quality care and access to innovative treatments.
  6. Expanded Neonatal Screening: Expand neonatal screening to identify rare diseases in newborns at an early stage, allowing for early treatment and intervention.

These strategies aim to improve awareness of rare diseases, facilitate access to specialized care and promote adherence to treatment, contributing to a better quality of life and outcomes for patients affected by these conditions.

How can early diagnosis of rare diseases impact patient outcomes and treatment options?

Early diagnosis of rare diseases can have a significant impact on patient outcomes and treatment options as follows:

  1. Better Prognosis: Identifying a rare disease early can allow appropriate medical and therapeutic interventions to be initiated, improving the patient’s prognosis.
  2. Prevention of Complications: With an early diagnosis, it is possible to prevent or minimize the development of complications associated with the rare disease, improving the patient’s quality of life.
  3. Access to Specific Treatments: Early diagnosis can facilitate access to specific treatments and innovative therapies that can be more effective when started early.
  4. Psychosocial support: An early diagnosis also allows the family and patient to receive adequate psychosocial support from the outset, helping them to deal with the emotional and practical challenges of the disease.
  5. Better Quality of Life: By starting treatment early, rare disease patients have the opportunity to improve their quality of life and cope with the disease more effectively.

In summary, early diagnosis of rare diseases is fundamental to optimizing clinical results, offering appropriate treatment options and providing comprehensive support for patients and their families.


Source: PENIDO, Maria Goretti Moreira Guimarães; VAISBICH, Maria Helena; PALMA, Lilian Monteiro Pereira; BRESOLIN, Nilzete Liberato. Rare Diseases: What Pediatricians Need to Know. Resid Pediatr., v. 14, n. 1, 2024. DOI: 10.25060/residpediatr-2024.v14n1-1062.

Este post também está disponível em: Português (Portuguese (Brazil))

Leave a Comment

RSS
Follow by Email
error: Este é um conteúdo protegido !!